MEPROSPAN Drug Patent Profile
✉ Email this page to a colleague
When do Meprospan patents expire, and what generic alternatives are available?
Meprospan is a drug marketed by Medpointe Pharm Hlc and is included in one NDA.
The generic ingredient in MEPROSPAN is meprobamate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meprospan
A generic version of MEPROSPAN was approved as meprobamate by INVAGEN PHARMS on February 27th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEPROSPAN?
- What are the global sales for MEPROSPAN?
- What is Average Wholesale Price for MEPROSPAN?
Summary for MEPROSPAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 33 |
| Patent Applications: | 5,000 |
| DailyMed Link: | MEPROSPAN at DailyMed |
US Patents and Regulatory Information for MEPROSPAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medpointe Pharm Hlc | MEPROSPAN | meprobamate | CAPSULE, EXTENDED RELEASE;ORAL | 011284-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Medpointe Pharm Hlc | MEPROSPAN | meprobamate | CAPSULE, EXTENDED RELEASE;ORAL | 011284-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
